Remimazolam for Colonoscopy in IBD Patients
Part of Digestive system clinical trials.
This study tests a newer sedative called remimazolam for people with inflammatory bowel disease (IBD) who are having a colonoscopy. The goal is to see if it works well and safely for sedation during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with Crohn's disease or ulcerative colitis for at least 6 months.
- You are scheduled for a colonoscopy for medical reasons or routine surveillance.
- You are not in a high-risk group for sedation (e.g., severe lung disease, sleep apnea, severe obesity, or allergies to the study drugs).
- You have not had multiple surgeries that removed large parts of your small intestine and colon.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether remimazolam, a newer sedative, works as well as midazolam (a common sedative) for keeping patients comfortable during endoscopy procedures that examine the stomach and pancreas. The study aims to see which medication has fewer side effects.
This trial tests a sedative called remimazolam for people who need a high-risk ERCP procedure (a scope exam of the bile ducts). It is looking at whether remimazolam can provide safe and effective sedation for patients with serious health problems.
This study compares two different sedative medicines, remimazolam and midazolam, to see which works better for people having a routine upper GI endoscopy (a camera test to look at your stomach and esophagus). If you are scheduled for this procedure and need sedation, you may be able to join.
This trial compares two sedative medications, remimazolam and propofol, to see which works better and is safer for people having a colonoscopy to remove polyps. It could help choose a sedation option with fewer side effects.
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
Hear when a new IBD (Inflammatory Bowel Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.